BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13/02/2018

FDA Director Proposes to Refuse Approval of New Oxycodone Hydrochloride Capsules

The FDA Director is proposing to reject a new drug application for oxycodone hydrochloride immediate-release oral capsules in three strengths, giving the manufacturer, Pharmaceutical Manufacturing Research Services, Inc., the chance to request a hearing.

Source: Federal Register — Food and Drug AdministrationOpen original release →